OR WAIT null SECS
May 01, 2020
The goal of the collaboration is to manufacture up to one billion does per year of mRNA-1273, Moderna’s vaccine against the novel coronavirus.
April 16, 2020
The technology center is dedicated to developing greener, safer chemistries for manufacturing pharmaceutical raw materials and intermediates.
April 15, 2020
ISPE’s Facility of the Year Awards for 2020 go to bio/pharma companies in eight award categories, including two winners in the new Social Impact category.
April 02, 2020
Risk levels should be considered when designing containment for pharmaceutical tableting equipment to enhance operator safety.
Whether refitting existing spaces or building new, the need for quick build times, flexibility, and production efficiency is driving trends in bio/pharma facility construction.
March 24, 2020
Thermo Fisher is focused on investing to expand three specific areas of demand: biologics, cell and gene therapy, and drug product development and commercial capabilities.
March 18, 2020
Technologies and methods for new and refurbished manufacturing facility construction expand capacity for new modalities and to ease shortages.
March 11, 2020
Through the agreement, Bora will obtain ownership of the entire Mississauga site, including all facilities, under the proper regulatory clearances.
March 02, 2020
The growing interest in developing cell and gene therapies has prompted industry investment to grow manufacturing capacity.
The last year has seen intense investment activity into raising cell and gene therapy manufacturing capacity.